Consensus nomenclature for in vivo imaging of reversibly binding radioligands

  • Robert B. Innis
  • , Vincent J. Cunningham
  • , Jacques Delforge
  • , Masahiro Fujita
  • , Albert Gjedde
  • , Roger N. Gunn
  • , James Holden
  • , Sylvain Houle
  • , Sung Cheng Huang
  • , Masanori Ichise
  • , Hidehiro Iida
  • , Hiroshi Ito
  • , Yuichi Kimura
  • , Robert A. Koeppe
  • , Gitte M. Knudsen
  • , Juhani Knuuti
  • , Adriaan A. Lammertsma
  • , Marc Laruelle
  • , Jean Logan
  • , Ralph Paul Maguire
  • Mark A. Mintun, Evan D. Morris, Ramin Parsey, Julie C. Price, Mark Slifstein, Vesna Sossi, Tetsuya Suhara, John R. Votaw, Dean F. Wong, Richard E. Carson

Research output: Contribution to journalReview articlepeer-review

1773 Scopus citations

Abstract

An international group of experts in pharmacokinetic modeling recommends a consensus nomenclature to describe in vivo molecular imaging of reversibly binding radioligands.

Original languageEnglish
Pages (from-to)1533-1539
Number of pages7
JournalJournal of Cerebral Blood Flow and Metabolism
Volume27
Issue number9
DOIs
StatePublished - Sep 7 2007

Keywords

  • Modeling
  • Molecular imaging
  • Nomenclature
  • PET
  • Radioligands
  • SPECT

Fingerprint

Dive into the research topics of 'Consensus nomenclature for in vivo imaging of reversibly binding radioligands'. Together they form a unique fingerprint.

Cite this